What is the recommended treatment for an extra‑axial intracranial hemorrhage?

Treatment of Extra-Axial Hemorrhage

The treatment of extra-axial intracranial hemorrhage depends critically on whether the patient is on antithrombotic therapy and requires immediate reversal, followed by neurosurgical evaluation for evacuation based on hemorrhage size, clinical deterioration, and mass effect.

Initial Management Framework

1. Antithrombotic Reversal (If Applicable)

The first priority is urgent reversal of any anticoagulation or antiplatelet therapy to prevent hematoma expansion, which directly impacts mortality and functional outcomes 1.

Vitamin K Antagonists (Warfarin)

• Discontinue immediately when intracranial hemorrhage is present 1
• Administer vitamin K 10 mg IV plus 3- or 4-factor prothrombin complex concentrate (PCC) if INR ≥ 1.4 1
  • PCC dosing is weight-based and varies by INR and PCC type
  • If PCC unavailable: Fresh frozen plasma (FFP) 10-15 mL/kg IV 1
• Repeat INR at 15-60 minutes, then every 6-8 hours for 24-48 hours 1
• If INR remains ≥ 1.4 after initial reversal: redose vitamin K 10 mg IV or consider FFP 1

Direct Oral Anticoagulants (DOACs)

For Dabigatran:

• Idarucizumab 5 g IV in two divided doses if administered within 3-5 half-lives or if renal insufficiency present 1
• If idarucizumab unavailable and renal insufficiency: consider hemodialysis 1
• Activated charcoal 50 g if within 2 hours of ingestion (intubated patients or low aspiration risk) 1

For Factor Xa Inhibitors (rivaroxaban, apixaban, edoxaban):

• 4-factor PCC 50 U/kg IV or activated PCC (aPCC) 50 U/kg IV if within 3-5 half-lives or liver failure 1
• Activated charcoal 50 g if within 2 hours of ingestion 1
• Do NOT use rFVIIa or FFP 1

Heparin

• Full-dose IV heparin: urgent reversal required 1
• Protamine sulfate 1 mg per 100 units of heparin given in previous 2-3 hours (maximum 50 mg single dose) 1
• Prophylactic subcutaneous heparin: reversal NOT routinely recommended unless aPTT significantly prolonged 1

Low Molecular Weight Heparin (LMWH)

• Protamine sulfate administered over 10 minutes 1:
  • Enoxaparin: 1 mg protamine per 1 mg enoxaparin if given within 8 hours; 0.5 mg per 1 mg if 8-12 hours 1
  • Other LMWHs: 1 mg protamine per 100 anti-Xa units (maximum 50 mg) 1

Thrombolytics

• Cryoprecipitate 10 units initial dose if thrombolytic given within 24 hours 1
• Alternative: tranexamic acid 10-15 mg/kg IV over 20 minutes or ε-aminocaproic acid 4-5 g IV 1
• Check fibrinogen; if <150 mg/dL, give additional cryoprecipitate 1

2. Neurosurgical Intervention

After addressing coagulopathy, immediate neurosurgical consultation is mandatory for all extra-axial hemorrhages.

Indications for Surgical Evacuation

Acute Epidural Hematoma (EDH):

• Emergency craniotomy is appropriate before neurological deterioration occurs 2
• EDH has 5% mortality with prompt intervention but is potentially lethal if delayed 2
• Critical pitfall: EDH is frequently mischaracterized as subdural hematoma on radiology reports (41.5% insufficient characterization rate), especially when non-lentiform, crossing suture lines, or ≤7 mm thick 3. Always correlate with site of traumatic impact (coup location) 3

Acute Subdural Hematoma (SDH):

• Immediate craniotomy once vital functions stabilized to prevent intracranial hypertension 2
• Mandatory ICP monitoring after clot evacuation 2
• Mortality ~50% even with operative treatment; outcome relates more to associated brain injury than clot itself 2

Chronic Subdural Hematoma:

• Twist drill evacuation under local anesthesia is treatment of choice 2
• Different entity with better prognosis than acute SDH

Special Populations

Neonates with Extra-Axial Hemorrhage:

• If presenting with refractory seizures, decreased consciousness, signs of increased ICP, or midline shift: ultrasound-guided percutaneous needle aspiration is highly effective 4, 5
• This minimally invasive bedside technique can aspirate 7-34 mL with immediate clinical improvement 5
• Avoids risks of standard neurosurgical decompression 5
• Complete seizure resolution achieved in reported cases 4

3. Monitoring and Supportive Care

• Intracranial pressure monitoring is essential after surgical evacuation 2
• Maintain optimal cerebral perfusion to prevent secondary brain injury 2
• Serial neurological assessments and repeat imaging as clinically indicated

Critical Caveats

1. Do NOT reverse VKA if cerebral venous thrombosis is suspected as the cause of hemorrhage 1
2. Assess risks/benefits before VKA reversal if concurrent symptomatic thrombosis, life-threatening ischemia, heparin-induced thrombocytopenia, or DIC present 1
3. Radiographic mischaracterization is common: Nearly half of EDH are mislabeled as SDH, particularly thin or atypical-appearing lesions 3. Verify diagnosis with neurosurgical consultation
4. Timing is critical: Hematoma expansion occurs rapidly in anticoagulated patients; every minute counts for reversal and surgical decision-making 1